Shares of Moderna Inc. (MRNA) were down 0.2% in trading on Thursday after the company said it had hired an Amgen executive to run commercial operations as it rolls out the first doses of its COVID-19 vaccine, in the U.S. and elsewhere. Corinne Le Goff, a pharmacist by trade and the former president of the U.S. business at Amgen Inc. (AMGN), will begin her role as chief commercial officer on Jan. 19, reporting to CEO Stéphane Bancel. Moderna's COVID-19 vaccine is the company's first authorized or approved product, and the company is now tasked with building a commercial enterprise to support the vaccine and any future authorized or approved products. Moderna's stock has rallied 553.2% over the last year, while the S&P 500 is up 15.4%.
-Jaimy Lee; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
January 07, 2021 11:05 ET (16:05 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.